Lymphoma Archives - Oncology Nurse Advisor Mon, 26 Feb 2024 15:09:47 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Lymphoma Archives - Oncology Nurse Advisor 32 32 Risk Stratification Can Predict Outcomes for CAR T-Cell Therapy in Lymphoma https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/risk-stratification-can-predict-outcomes-for-car-t-cell-therapy-in-lymphoma/ Mon, 26 Feb 2024 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116760 Pediatric Hodgkin Lymphoma Trials Show Net Reduction in Late Cardiotoxicity https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/pediatric-hodgkin-lymphoma-trials-reduce-cardiotoxicity/ Mon, 12 Feb 2024 14:15:00 +0000 https://www.oncologynurseadvisor.com/?p=116577 Plasmablastic Lymphoma Remains Challenging to Treat, Resulting in Poor Prognosis  https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/plasmablastic-lymphoma-challenge-treat-poor-prognostic-factors-treatment/ Wed, 07 Feb 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116553 MRD Status Predicts Outcomes in Patients With Previously Untreated FL https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/follicular-lymphoma-mrd-minimal-disease-predict-outcome-treatment-risk/ Thu, 01 Feb 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116451 JAK1 TKI Golidocitinib Shows Promise in Relapsed/Refractory PTCL https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/ptcl-lymphoma-jak1-tki-golidocitinib-promise-treatment-risk/ Wed, 31 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116313 Analysis of Venous Thromboembolism Risk in Patients With Lymphoma https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/lymphoma-venous-thromboemnbolism-vte-risk-treatment-patients-analysis/ Thu, 25 Jan 2024 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116225 CD5 CAR-T Cells Induce Responses in Relapsed/Refractory T-Cell Lymphomas https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/cd5-car-t-cells-induce-responses-relapsed-refractory-t-cell-lymphomas/ Tue, 23 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116042 Liso-Cel Deemed Cost-Effective as Second-Line Treatment for DLBCL https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/liso-cel-cost-effective-dlbcl/ Tue, 16 Jan 2024 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=116038 Frontline Tazemetostat May Induce Complete Metabolic Response in FL https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/follicular-lymphoma-frontline-tazemotostat-induce-metabolic-response-treatment/ Tue, 16 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116035 CAR-T Therapy Not Cost-Effective for DLBCL in the Second-Line Setting https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/lymphoma-dlbcl-axicel-cart-therapy-cost-effective-treatment-risk/ Tue, 09 Jan 2024 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115918